Drug Type siRNA |
Synonyms |
Target |
Action inhibitors |
Mechanism CFB inhibitors(Complement factor B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Phase 1 | Canada | 15 Nov 2023 | |
Rheumatoid Arthritis | Phase 1 | United Kingdom | 15 Nov 2023 |